Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

This study has been completed.
Information provided by (Responsible Party):
Øystein Bruserud, University of Bergen Identifier:
First received: October 14, 2009
Last updated: June 23, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)